Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Westwater Resources
WWR
$58.4M
| $32K | ﹤0.01% |
+499
| New | +$37.2K |
2016 Q3
0 quarters
|
|
|
AUMN
3277
DELISTED
Golden Minerals Company
AUMN
| $32K | ﹤0.01% |
+1,720
| New | +$36.6K |
2016 Q3
0 quarters
|
|
3278
Viking Therapeutics
VKTX
$3.53B
| $30K | ﹤0.01% |
+21,300
| New | +$28.2K |
2016 Q3
0 quarters
|
|
|
TLOG
3279
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
| $30K | ﹤0.01% |
192,100
-3,000
| -2% | -$693 |
2015 Q4
3 quarters
|
|
|
TCCO
3280
DELISTED
Technical Communications Corporation
TCCO
| $28K | ﹤0.01% |
10,603
-1,597
| -13% | -$4.51K |
2013 Q2
13 quarters
|
|
3281
Armata Pharmaceuticals
ARMP
$144M
| $26K | ﹤0.01% |
121
+6
| +5% | +$1.38K |
2016 Q2
1 quarter
|
|
3282
China Pharma Holdings
CPHI
$41.3M
| $26K | ﹤0.01% |
240
+49
| +26% | +$6.28K |
2013 Q2
13 quarters
|
|
|
PRZM
3283
DELISTED
Prism Technologies Group, Inc
PRZM
| $26K | ﹤0.01% |
127,200
+19,700
| +18% | +$4.69K |
2013 Q2
13 quarters
|
|
|
NOTV
3284
DELISTED
Inotiv
NOTV
| $25K | ﹤0.01% |
21,500
+3,800
| +21% | +$4.56K |
2015 Q1
6 quarters
|
|
3285
US Gold Corp
USAU
$230M
| $25K | ﹤0.01% |
497
+322
| +184% | +$18.9K |
2016 Q2
1 quarter
|
|
3286
Xtant Medical Holdings
XTNT
$45M
| $25K | ﹤0.01% |
+1,808
| New | +$33.3K |
2016 Q3
0 quarters
|
|
3287
Newegg Commerce
NEGG
$243M
| $22K | ﹤0.01% |
88
-10
| -10% | -$2.66K |
2015 Q4
3 quarters
|
|
|
TAIT
3288
DELISTED
Taitron Components
TAIT
| $19K | ﹤0.01% |
16,200
+5,600
| +53% | +$6.28K |
2016 Q2
1 quarter
|
|
3289
Viridian Therapeutics
VRDN
$2.08B
| $19K | ﹤0.01% |
168
+100
| +147% | +$11.2K |
2016 Q2
1 quarter
|
|
|
CPRX
3290
DELISTED
Catalyst Pharmaceutical
CPRX
| $16K | ﹤0.01% |
+15,000
| New | +$13.5K |
2016 Q3
0 quarters
|
|
3291
TRX Gold Corp
TRX
$367M
| $15K | ﹤0.01% |
19,200
-74,700
| -80% | -$76.9K |
2016 Q1
2 quarters
|
|
|
TEAR
3292
DELISTED
TearLab Corporation
TEAR
| $13K | ﹤0.01% |
+1,980
| New | +$14.7K |
2016 Q3
0 quarters
|
|
|
DRYS
3293
DELISTED
DryShips Inc. Common Stock
DRYS
| – | – |
0
| – | – |
2016 Q3
0 quarters
|
|
|
UQM
3294
DELISTED
UQM Technologies, Inc.
UQM
| $11K | ﹤0.01% |
17,799
+2,300
| +15% | +$1.41K |
2016 Q1
2 quarters
|
|
3295
Nuwellis
NUWE
$2.14M
| – | – |
0
| – | – |
2015 Q4
3 quarters
|
|
|
AGIG
3296
Abundia Global Impact Group
AGIG
$41.5M
| $2K | ﹤0.01% |
102
-639
| -86% | -$16K |
2014 Q1
10 quarters
|
|
3297
Advance Auto Parts
AAP
$2.56B
| – | – |
-393,150
| Closed | -$63.5M | – |
|
3298
Apple
AAPL
$4.97T
| – | – |
-4,384,132
| Closed | -$105M | – |
|
|
AAT
3299
American Assets Trust
AAT
$1.33B
| – | – |
-30,800
| Closed | -$1.31M | – |
|
3300
Acadia Healthcare
ACHC
$2.65B
| – | – |
-65,315
| Closed | -$3.62M | – |
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.